Analysts Set Mylan (MYL) PT at $47.23

Shares of Mylan (NASDAQ:MYL) have been assigned an average recommendation of “Buy” from the twenty-three ratings firms that are currently covering the stock, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $47.23.

Several equities analysts have recently weighed in on the company. Goldman Sachs raised their price target on Mylan from $46.00 to $52.00 and gave the company a “buy” rating in a report on Thursday, January 11th. Citigroup restated a “buy” rating and set a $58.00 price target (up from $48.00) on shares of Mylan in a report on Thursday, January 4th. Leerink Swann assumed coverage on Mylan in a report on Tuesday, January 2nd. They set a “market perform” rating and a $44.00 price target for the company. JPMorgan Chase set a $53.00 price target on Mylan and gave the company a “buy” rating in a report on Friday, February 16th. Finally, Cantor Fitzgerald set a $41.00 price target on Mylan and gave the company a “hold” rating in a report on Wednesday, April 11th.

How to Become a New Pot Stock Millionaire

In other Mylan news, Director Robert J. Coury sold 150,000 shares of the firm’s stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $40.10, for a total value of $6,015,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Paul Campbell sold 7,030 shares of the firm’s stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $44.01, for a total value of $309,390.30. Following the completion of the transaction, the insider now directly owns 17,054 shares in the company, valued at $750,546.54. The disclosure for this sale can be found here. Insiders have sold 269,287 shares of company stock worth $11,034,960 over the last ninety days. 0.69% of the stock is currently owned by insiders.



A number of large investors have recently made changes to their positions in MYL. Rational Advisors LLC purchased a new position in shares of Mylan during the 4th quarter valued at about $190,000. First Personal Financial Services lifted its position in shares of Mylan by 77.1% during the 4th quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock valued at $205,000 after buying an additional 2,106 shares in the last quarter. Lombard Odier Asset Management Europe Ltd purchased a new position in shares of Mylan during the 4th quarter valued at about $209,000. Mycio Wealth Partners LLC purchased a new position in shares of Mylan during the 4th quarter valued at about $212,000. Finally, Advisor Partners LLC purchased a new position in shares of Mylan during the 4th quarter valued at about $214,000. 84.53% of the stock is currently owned by institutional investors and hedge funds.

MYL traded down $0.09 during trading on Thursday, reaching $40.72. The stock had a trading volume of 3,430,277 shares, compared to its average volume of 3,627,779. The company has a current ratio of 1.13, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The company has a market cap of $20,961.92, a price-to-earnings ratio of 8.93, a price-to-earnings-growth ratio of 1.32 and a beta of 1.34. Mylan has a one year low of $29.39 and a one year high of $47.82.

Mylan (NASDAQ:MYL) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.29 billion. Mylan had a return on equity of 19.14% and a net margin of 5.84%. The firm’s quarterly revenue was down .9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.57 earnings per share. analysts predict that Mylan will post 5.36 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Analysts Set Mylan (MYL) PT at $47.23” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://stocknewstimes.com/2018/04/22/analysts-set-mylan-myl-pt-at-47-23.html.

About Mylan

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply